Skip to main content
HLF logo

HLF · Herbalife Ltd.

Track HLF — free
$12.44 -0.13 (-1.00%)
Market Cap
$1.32B
Shares
104.80M
Volume · Oct 5 393.64K Avg daily vol (3M) 1.55M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$12.56 Open$12.32 Day$12.30–12.63 52W close$7.75–19.96 Avg vol 30d1.6M Short int9.0M · 8.6% float · 5.2d Short vol58% Last earningsAug 5, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 4 wks
filed Aug 5, 2026
call held Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$5.20B
Trailing 12 months
Net income (TTM)
$164.20M
Trailing 12 months
Revenue growth YoY
+5.4%
Year over year
Operating margin
9.5%
Trailing 12 months
P / E (TTM)
8.1
Trailing earnings · reciprocal yield 12.3%
FCF yield
24.5%
TTM · current market cap
Return on invested capital
32.1%
Trailing 12 months
Net cash
−$1.65B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.2%
Year over year · more shares
Price change (1Y)
+44.4%
Trailing year
Short interest
8.6%
Latest settlement · 5.2 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Herbalife delivered fourth consecutive quarter of net sales growth, beating constant-currency guidance, while narrowing full-year guidance and raising constant-currency adjusted EBITDA midpoint; however, a $94.6M loss on debt extinguishment drove a GAAP net loss of $26.3M and diluted loss per share of $(0.25).

Bullish
  • + Net sales of $1.3B, up 5.4% YoY, at top of guidance; constant-currency growth of 5.8% exceeded guidance by ~80 bps
  • + Full-year 2026 adjusted EBITDA constant-currency midpoint raised; range tightened
  • + Full-year 2026 net sales guidance range narrowed with midpoint raised
Bearish
  • − Adjusted effective tax rate jumped to 43.2% from 27.7%, a ~$0.14 unfavorable impact to adjusted diluted EPS; full-year adjusted tax rate now ~35%
  • − Gross profit margin declined 30 bps YoY to 77.7% on country mix and higher costs
  • − FX was a headwind: 40 bps drag on reported net sales, ~$8M drag on adjusted EBITDA, and reported full-year adjusted EBITDA midpoint lowered
  • − EMEA net sales declined 3.5% reported / 5.6% constant currency on 12% volume decline
  • − China net sales declined 24.5% reported / 29% constant currency on 29% volume decline

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −11%
below
Price vs 50-day avg +3%
above
RSI (14) 55
neutral
MACD trend Positive
52-week position 39%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +3%
trailing
6-month return −19%
trailing
YTD return −3%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $12 › 200d $14 — 200d above 50d
Institutional flow Distributing
1 of 240 funds reported for Sep 30 · net -107 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.61% of float · ▲ +3.4% MoM · 5.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
240 holders — mid 3-yr range
Squeeze score 69
elevated · 0–100
Fundamentals
Excellent
Revenue growth +1%
Y/Y
Gross margin 78%
contracting
EPS growth −12%
Y/Y
Free cash flow $252.9M
Valuation P/E 8.1
below peers
Buyback $985.5M
remaining
Balance sheet $41.7M
net cash
Quant / Vol
risk profile
Very High
Volatility 59%
annualized · 1-yr
Max drawdown −45%
past year
ATR 3.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 3
Latest guidance · from the 8-K filed Aug 5, 2026
Depreciation and amortization, and amortization of SaaS implemen · Full Year 2026 Initiated $140M – $150M
Guided vs delivered · last 3 settled
Reported diluted EPS the second quarter of 2021
guided $1.17 – $1.32
$1.31 In line
Reported diluted EPS full year 2021
guided $4.41 – $4.81
$4.13 Miss −10.4%
Reported diluted EPS first quarter 2021
guided $0.95 – $1.10
$1.33 Beat +29.8%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−11% Bearish
Price vs 50-day avg
+3% Bullish
RSI (14)
55 Neutral
MACD trend
Positive Bullish
52-week position
39% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $12 › 200d $14 — 200d above 50d
Institutional flow Distributing
1 of 240 funds reported for Sep 30 · net -107 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.61% of float · ▲ +3.4% MoM · 5.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
240 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $8 Now $13 · 39% Range high $20
vs 200-day avg -11% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA at constant currency non-GAAP $174.4M Q2 2026 —
GAAP → non-GAAP reconciliation
GAAP Adjusted EBITDA $657.6M
+$8.5M Interest income
+$25.9M Inventory write-downs
+$44.1M Share-based compensation expenses
+$5.9M Other expenses (income)
= Credit Agreement EBITDA $742M
Inventory write-downs $3.5M Q2 2026 —
Net debt non-GAAP $1.67B Q2 2026 —
Net income margin -2% Six Months Ended June 30, 2026 —
Share-based compensation expenses $10.4M Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
HLF
Herbalife Ltd.
this stock
$1.32B -2.6% +0.9% 8.1 8.6%
JBS
Jbs N.V.
$38.06B -19.1% — — 1.2%
KHC
Kraft Heinz Co
$28.02B -8.5% -0.1% — 7.9%
GIS
General Mills Inc
$17.99B -31.2% +4.1% — 8.4%
SJM
J M SMUCKER Co
$12.93B +19.8% +3.7% — 4.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
240
% held
113.6%
Reported
1 of 240
Top holder
BAUPOST GROUP LLC/MA
Held Float
View
Held by Funds
Fund positions
85
View
Short & Settlement
Short Interest Rising
Shares short
9.0M
Days to cover
5.2d
Change
+295.4K sh
View
Short Volume
Short vol %
58%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
44
Value
$535
As of
Sep 3, 2026
View
Off-Exchange
Off-exchange %
41.7%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$5.0B
Net income (FY)
$228.3M
EPS diluted
$2.20
View
Buybacks
Authorized
$1.5B
Remaining
$985.5M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 31, 2026
This year
13
View
Proposed Sales
Value
$123.2K
Shares
10.0K
Filed
May 19, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 26, 2026
View

Performance

5D 20D 120D MTD YTD
HLF +0.1% +3.2% -19.1% +3.5% -2.6%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY +0.3% +3.7% -31.3% +2.6% -15.4%

Capital returns

Buyback program · as of Sep 30, 2025
Authorized
$1.50B
Spent (derived)
$514.50M
Remaining
$985.50M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1180262 CUSIP G4412G101 13F (30d) 5 filings 5 filers Visit website Investor relations